Orthopedic Surgery Doctors in Mount Clemens, MI Accepting Medicare

9 Orthopedic Surgery doctors found. Showing 1 - 9

Saad Mohammad, DO Orthopaedic Surgery Medicare: May Accept Medicare Assignments Practice Location: 1000 Harrington St, Mount Clemens, MI 48043 Phone: 586-493-8142    Fax: 586-493-3250

Dr. Michael Anthony Wagner, D.O. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1000 Harrington St, Mount Clemens, MI 48043 Phone: 586-493-8000

Michael Bodine, DO Orthopaedic Surgery Medicare: Medicare Enrolled Practice Location: 1000 Harrington St, Mount Clemens, MI 48043 Phone: 586-493-8142    Fax: 586-493-3250

Michael Dirkx, D.O. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1000 Harrington St, Mount Clemens, MI 48043 Phone: 586-493-8000

Adam Lorenzo, DO Orthopaedic Surgery Medicare: Medicare Enrolled Practice Location: 1000 Harrington St, Mount Clemens, MI 48043 Phone: 586-493-8142    Fax: 586-493-3250

Roy Frederick Small, DO Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1000 Harrington St, Mount Clemens, MI 48043 Phone: 586-493-8142    Fax: 586-493-3250

Phillip Anderson, DO Orthopaedic Surgery Medicare: Medicare Enrolled Practice Location: 1000 Harrington St, Mount Clemens, MI 48043 Phone: 586-790-9003

Gino Michael Lombardo, DO Orthopaedic Surgery Medicare: Medicare Enrolled Practice Location: 1000 Harrington St, Mount Clemens, MI 48043 Phone: 586-790-9003

Dr. Andy Michalowitz, D.O. Orthopaedic Surgery Medicare: Medicare Enrolled Practice Location: 1000 Harrington St, Mount Clemens, MI 48043 Phone: 586-493-8195

News Archive

Fragile X syndrome iPS cells and embryonic stem cells behave differently: Study

In the last three years, a new technique for reprogramming adult cells has given scientists an easier and less controversial way to harness the power of embryonic-like stem cells to study human disease from its earliest beginnings in hopes of gleaning new insights into the root causes of disease and developing new therapies.

New approaches to treating amblyopia

Amblyopia, commonly known as "lazy-eye," has been classically treated by patching the strong eye to force the weaker eye to be used. However, the concept of binocular dysfunction, in which the brain suppresses the image from the weaker eye in favor of the stronger eye, has motivated new approaches to amblyopia treatment.

Roche and Pharmasset start phase IIb clinical trial of R7128 nucleoside polymerase inhibitor for chronic hepatitis C

Pharmasset, Inc. and Roche have announced that the first patient has been dosed in a Phase IIb study of R7128, the nucleoside polymerase inhibitor most advanced in development for the treatment of chronic hepatitis C (HCV).

New law to increase employment-based coverage for children

A recent law that requires group health plans and insurers to make dependent coverage available for children until they attain the age of 26 will increase employment-based coverage by estimates ranging from 680,000 to 2.12 million individuals, according to recently released regulations.

Read more Medical News

› Verified 3 days ago